Prevalence and Control of Diabetes and Impaired Fasting Glucose in New York City

OBJECTIVE—To determine the prevalence of diabetes and impaired fasting glucose (IFG) and to assess clinical management indicators among adults with diabetes in a representative sample of New York City adults. RESEARCH DESIGN AND METHODS—In 2004, New York City implemented the first community-level Health and Nutrition Examination Survey (NYC HANES), modeled after the National Health and Nutrition Examination Survey (NHANES). We used an interview to determine previously diagnosed diabetes and measured fasting plasma glucose to determine undiagnosed diabetes and IFG in a probability sample of 1,336 New York City adults. We assessed glycemic control and other clinical indicators using standardized NHANES protocols. RESULTS—The prevalence of diabetes among New York City adults was 12.5% (95% CI 10.3–15.1): 8.7% diagnosed and 3.8% undiagnosed. Nearly one-fourth (23.5%) of adults had IFG. Asians had the highest prevalence of impaired glucose metabolism (diabetes 16.1%, IFG 32.4%) but were significantly less likely to be obese. Among adults with diagnosed diabetes, less than one-half (45%) had A1C levels <7%; one-half (50%) had elevated blood pressure measures at interview, 43% of whom were not on antihypertensive medications; nearly two-thirds (66%) had elevated LDL levels, and only 10% had their glucose, blood pressure, and cholesterol all at or below recommended levels. Most adults (84%) with diagnosed diabetes were on medication, but only 12% were receiving insulin. CONCLUSIONS—In New York City, diabetes and IFG are widespread. Policies and structural interventions to promote physical activity and healthy eating should be prioritized. Improved disease management systems are needed for people with diabetes.

[1]  S. Findley,et al.  Prevalence and Control of Diabetes and Impaired Fasting Glucose in New York City , 2009, Diabetes Care.

[2]  B. Zinman,et al.  Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy , 2009, Diabetes Care.

[3]  T. Frieden,et al.  Obesity and Diabetes in New York City, 2002 and 2004 , 2008, Preventing chronic disease.

[4]  Thodoris D. Karapantsios,et al.  Standards of Medical Care in Diabetes—2008 The recommendations in this article are based on the evidence reviewed in the following publication: Standards of care for diabetes (Technical Review). Diabetes Care 17:1514–1522, 1994. Originally approved 1988. Most recent review/revision, October 2007. , 2008, Diabetes Care.

[5]  P. Zimmet,et al.  Diagnosis and classification of diabetes mellitus , 2002 .

[6]  The prevalence of cardiovascular risk conditions and awareness among a Latino subgroup: Dominicans in northern Manhattan. , 2008, Ethnicity & disease.

[7]  J. Shaw,et al.  Risk of Cardiovascular and All-Cause Mortality in Individuals With Diabetes Mellitus, Impaired Fasting Glucose, and Impaired Glucose Tolerance: The Australian Diabetes, Obesity, and Lifestyle Study (AusDiab) , 2007, Circulation.

[8]  S. Saydah,et al.  Race and ethnic differences in glycemic control among adults with diagnosed diabetes in the United States. , 2007, Ethnicity & disease.

[9]  G. Mensah,et al.  Socioeconomic status and trends in disparities in 4 major risk factors for cardiovascular disease among US adults, 1971-2002. , 2006, Archives of internal medicine.

[10]  R. Heine,et al.  Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy , 2006, Diabetologia.

[11]  Jenna Mandel-Ricci,et al.  Study Design and Participation Rates of the New York City Health and Nutrition Examination Survey, 2004 , 2006, Preventing chronic disease.

[12]  Michael M. Engelgau,et al.  Prevalence of Diabetes and Impaired Fasting Glucose in Adults in the U.S. Population , 2006, Diabetes Care.

[13]  M. Engelgau,et al.  Changes in incidence of diabetes in U.S. adults, 1997-2003. , 2006, American journal of preventive medicine.

[14]  T. Frieden,et al.  Trends and racial/ethnic disparities in gestational diabetes among pregnant women in New York City, 1990-2001. , 2005, American journal of public health.

[15]  A. Mokdad,et al.  Geographic variation in the prevalence of obesity, diabetes, and obesity-related behaviors. , 2005, Obesity research.

[16]  P. Bingley,et al.  Mortality of South Asian patients with insulin‐treated diabetes mellitus in the United Kingdom: a cohort study , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[17]  S. Fortmann,et al.  Coronary heart disease mortality for six ethnic groups in California, 1990-2000. , 2004, Annals of epidemiology.

[18]  C. Nishida,et al.  Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies , 2004, The Lancet.

[19]  E. Boyko,et al.  Type 2 diabetes prevalence in Asian Americans: results of a national health survey. , 2004, Diabetes care.

[20]  P. Charney,et al.  Preventing cardiovascular disease in diabetes and glucose intolerance: evidence and implications for care. , 2003, Primary care.

[21]  John Wilding,et al.  Obesity and Diabetes , 2010, Experimental and Clinical Endocrinology & Diabetes.

[22]  S. Fowler,et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .

[23]  E. Feskens,et al.  Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria , 1999, The Lancet.

[24]  John P H Wilding,et al.  Obesity and diabetes. , 1999, Bailliere's best practice & research. Clinical endocrinology & metabolism.

[25]  S. Yusuf,et al.  The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. , 1999, Diabetes care.